Syngene set for phase-2 trial of Covid oral tablet vaccineVaxart had started trials of its oral recombinant tablet vaccine in October last year. It enrolled 96 participants at four centres in the U...
Oral Covid vaccine protects against disease, transmission: StudyThe research, published in the journal Science Translational Medicine, demonstrates the potential of the vaccine to work through the mucosa...
'Meme stock' rally pauses as Redditors focus on biotech stocksOf the top 10 stocks trending on trading-focused social media site Stocktwits, vaccine developers Novavax Inc and Vaxart Inc were in the th...